{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:16:26Z","timestamp":1788714986891,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,27]]},"DOI":"10.7759\/cureus.63303","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:50:51Z","timestamp":1719514251000},"source":"Crossref","is-referenced-by-count":2,"title":["Rhabdomyolysis Associated With Febuxostat in a Non-Chronic Kidney Disease (CKD) Patient: Diagnostic and Management Challenges"],"prefix":"10.7759","author":[{"given":"Armend","family":"Balidemaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Kholoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-76174-1.00036-5","article-title":"36 - Rhabdomyolysis","author":"Harmelink MM","year":"2023","unstructured":"Harmelink MM. 36 - Rhabdomyolysis. Nelson Pediatric Symptom-Based Diagnosis: Common Diseases and their Mimics (Second Edition). Kliegman RM, Toth H, Bordini BJ, Basel D (ed): Elsevier, Philadelphia; 2023. 619-29. 10.1016\/B978-0-323-76174-1.00036-5"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31519","article-title":"A rare case of rhabdomyolysis","volume":"14","author":"Pombo F","year":"2022","unstructured":"Pombo F, Raposo A, Martins MD, Ferreira I, Pires L. A rare case of rhabdomyolysis. Cureus. 2022, 14:e31519. 10.7759\/cureus.31519","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1070465","article-title":"Case report: Rhabdomyolysis in children in acute and chronic disease\u2014a challenging condition in pediatric emergency medicine","volume":"11","author":"Mand N","year":"2023","unstructured":"Mand N, Donath C, Leonhardt A, Weber S, K\u00f6mhoff M. Case report: Rhabdomyolysis in children in acute and chronic disease\u2014a challenging condition in pediatric emergency medicine. Front Pediatr. 2023, 11:1070465. 10.3389\/fped.2023.1070465","journal-title":"Front Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.22265\/acnef.9.1.520","article-title":"Rhabdomyolysis caused by exercise","volume":"9","author":"Reyes DA","year":"2022","unstructured":"Reyes DA, Cruz-Echeverry EJ, Echeverry-Piedrahita DR, G\u00f3mez-Gonz\u00e1lez JF, Aguirre-Fl\u00f3rez M. Rhabdomyolysis caused by exercise. Rev Colomb Nefrol. 2022, 9:10.22265\/acnef.9.1.520","journal-title":"Rev Colomb Nefrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5348\/101321Z01EB2022CR","article-title":"A case of rhabdomyolysis with rigors","volume":"13","author":"Bliss E","year":"2022","unstructured":"Bliss E, Vellani SD, Spencer C, Federman D, Khuder S, Akpunonu B. A case of rhabdomyolysis with rigors. Int J Case Rep Images IJCRI. 2022, 13:26-30. 10.5348\/101321Z01EB2022CR","journal-title":"Int J Case Rep Images IJCRI"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14558","article-title":"Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis","volume":"26","author":"Tsai PH","year":"2023","unstructured":"Tsai PH, Kuo CF, Liu JR, Li PR, See LC. Effect of febuxostat on adverse events and mortality in gout in Taiwan: An interrupted time series analysis. Int J Rheum Dis. 2023, 26:471-9. 10.1111\/1756-185X.14558","journal-title":"Int J Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12144","article-title":"Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease","volume":"39","author":"Kang Y","year":"2014","unstructured":"Kang Y, Kim MJ, Jang HN, et al.. Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease. J Clin Pharm Ther. 2014, 39:328-30. 10.1111\/jcpt.12144","journal-title":"J Clin Pharm Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15655","article-title":"Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials","volume":"89","author":"Mitsuboshi S","year":"2023","unstructured":"Mitsuboshi S, Kotake K. Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2023, 89:956-66. 10.1111\/bcp.15655","journal-title":"Br J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18502\/jimc.v6i1.11852","article-title":"Xenobiotic-induced rhabdomyolysis and its relationship with paraclinical variables in poisoned patients","author":"Nahandi MZ","year":"2022","unstructured":"Nahandi MZ, Kazemifar AM, Rafiee S, Mohammadi AB. Xenobiotic-induced rhabdomyolysis and its relationship with paraclinical variables in poisoned patients. J Iran Med Counc. 2022, 10.18502\/jimc.v6i1.11852","journal-title":"J Iran Med Counc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3897\/folmed.65.e81145","article-title":"Comparison of rhabdomyolysis in acutely intoxicated patients with psychotropic and chemical substances","volume":"65","author":"Babulovska A","year":"2023","unstructured":"Babulovska A, Caparovska D, Velikj Stefanovska V, et al.. Comparison of rhabdomyolysis in acutely intoxicated patients with psychotropic and chemical substances. Folia Med (Plovdiv). 2023, 65:407-14. 10.3897\/folmed.65.e81145","journal-title":"Folia Med (Plovdiv)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020946299","article-title":"Suspected drug-induced rhabdomyolysis from the combination of Atorvastatin, Amiodarone, and Ciprofloxacin","volume":"55","author":"Cowley E","year":"2021","unstructured":"Cowley E, Omar MA. Suspected drug-induced rhabdomyolysis from the combination of Atorvastatin, Amiodarone, and Ciprofloxacin. Ann Pharmacother. 2021, 55:415-6. 10.1177\/1060028020946299","journal-title":"Ann Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-022-01978-4","article-title":"Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique","volume":"22","author":"Kunakorntham P","year":"2022","unstructured":"Kunakorntham P, Pattanaprateep O, Dejthevaporn C, Thammasudjarit R, Thakkinstian A. Detection of statin-induced rhabdomyolysis and muscular related adverse events through data mining technique. BMC Med Inform Decis Mak. 2022, 22:233. 10.1186\/s12911-022-01978-4","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07254-0","article-title":"Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report","volume":"22","author":"Wang W","year":"2022","unstructured":"Wang W, Lu X, Li C, Teng W, Cui W. Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report. BMC Infect Dis. 2022, 22:365. 10.1186\/s12879-022-07254-0","journal-title":"BMC Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2478\/jccm-2020-0032","article-title":"Rhabdomyolysis-induced acute renal injury in a schizophrenic patient","volume":"6","author":"Tiglis M","year":"2020","unstructured":"Tiglis M, Hurmuzache T, Bologa C, Neagu TP, Mirea L, Grintescu IM. Rhabdomyolysis-induced acute renal injury in a schizophrenic patient. J Crit Care Med. 2020, 6:249-52. 10.2478\/jccm-2020-0032","journal-title":"J Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5812\/jnp.11","article-title":"Malignant drug-induced rhabdomyolysis","volume":"1","author":"Gheshlaghi F","year":"2012","unstructured":"Gheshlaghi F. Malignant drug-induced rhabdomyolysis. J Nephropathol. 2012, 1:59-60. 10.5812\/jnp.11","journal-title":"J Nephropathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27078","article-title":"Association of rhabdomyolysis with nebivolol","volume":"63","author":"Notturno F","year":"2021","unstructured":"Notturno F, Uncini A. Association of rhabdomyolysis with nebivolol. Muscle Nerve. 2021, 63:E1-2. 10.1002\/mus.27078","journal-title":"Muscle Nerve"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34625","article-title":"Rhabdomyolysis-induced acute kidney injury (AKI) in a young bodybuilder: A case report","volume":"15","author":"Parammal Alikutty J","year":"2023","unstructured":"Parammal Alikutty J, Raj A, Soofi SK, et al.. Rhabdomyolysis-induced acute kidney injury (AKI) in a young bodybuilder: A case report. Cureus. 2023, 15:e34625. 10.7759\/cureus.34625","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2023-003765","article-title":"Rosuvastatin-induced rhabdomyolysis: Case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients","volume":"31","author":"Niedrig DF","year":"2024","unstructured":"Niedrig DF, Pyra M, Lussmann R, Serra A, Russmann S. Rosuvastatin-induced rhabdomyolysis: Case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients. Eur J Hosp Pharm. 2024, 31:281-4. 10.1136\/ejhpharm-2023-003765","journal-title":"Eur J Hosp Pharm"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08280816","article-title":"Risk of febuxostat-associated myopathy in patients with CKD","volume":"12","author":"Liu CT","year":"2017","unstructured":"Liu CT, Chen CY, Hsu CY, Huang PH, Lin FY, Chen JW, Lin SJ. Risk of febuxostat-associated myopathy in patients with CKD. Clin J Am Soc Nephrol. 2017, 12:744-50. 10.2215\/CJN.08280816","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5694\/mja14.01404","article-title":"Febuxostat-associated rhabdomyolysis in chronic renal failure","volume":"203","author":"Ghosh D","year":"2015","unstructured":"Ghosh D, McGann PM, Furlong TJ, Day RO. Febuxostat-associated rhabdomyolysis in chronic renal failure. Med J Aust. 2015, 203:107-8. 10.5694\/mja14.01404","journal-title":"Med J Aust"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/264893-rhabdomyolysis-associated-with-febuxostat-in-a-non-chronic-kidney-disease-ckd-patient-diagnostic-and-management-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:51:08Z","timestamp":1719514268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/264893-rhabdomyolysis-associated-with-febuxostat-in-a-non-chronic-kidney-disease-ckd-patient-diagnostic-and-management-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.63303","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,27]]}}}